Skip to main content

Ellagic Acid and Its Role in Chronic Diseases

Part of the Advances in Experimental Medicine and Biology book series (AEMB,volume 928)

Abstract

Ellagic acid is a natural anti-oxidant phenol found in numerous fruits and vegetables, in particular pomegranate, persimmon, raspberry, black raspberry, strawberry, peach, plumes, nuts (walnuts, almonds), and wine. The anti-proliferative and anti-oxidant properties of ellagic acid have prompted research into its potential health benefits. The aim of this chapter will be to summarize potential benefits of ellagic acid supplementation in chronic diseases.

Keywords

  • Ellagic acid
  • Cancer
  • Chronic inflammation
  • Diabetes

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-3-319-41334-1_20
  • Chapter length: 7 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   169.00
Price excludes VAT (USA)
  • ISBN: 978-3-319-41334-1
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   219.99
Price excludes VAT (USA)
Hardcover Book
USD   219.99
Price excludes VAT (USA)
Fig. 20.1

References

  1. Zamora-Ros R, Knaze V, Luján-Barroso L, Slimani N, Romieu I, Fedirko V, de Magistris MS, Ericson U, Amiano P, Trichopoulou A, Dilis V, Naska A, Engeset D, Skeie G, Cassidy A, Overvad K, Peeters PH, Huerta JM, Sánchez MJ, Quirós JR, Sacerdote C, Grioni S, Tumino R, Johansson G, Johansson I, Drake I, Crowe FL, Barricarte A, Kaaks R, Teucher B, Bueno-de-Mesquita HB, van Rossum CT, Norat T, Romaguera D, Vergnaud AC, Tjønneland A, Halkjær J, Clavel-Chapelon F, Boutron-Ruault MC, Touillaud M, Salvini S, Khaw KT, Wareham N, Boeing H, Förster J, Riboli E, González CA (2011) Estimated dietary intakes of flavonols, flavanones and flavones in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24 hour dietary recall cohort. Br J Nutr 106(12):1915–1925

    CAS  CrossRef  PubMed  Google Scholar 

  2. Seeram NP, Zhang Y, McKeever R, Henning SM, Lee RP, Suchard MA, Li Z, Chen S, Thames G, Zerlin A, Nguyen M, Wang D, Dreher M, Heber D (2008) Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects. J Med Food 11(2):390–394

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  3. Larrosa M, Tomás-Barberán FA, Espín JC (2006) The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. J Nutr Biochem 17(9):611–625

    CAS  CrossRef  PubMed  Google Scholar 

  4. Gil MI, Tomás-Barberán FA, Hess-Pierce B, Holcroft DM, Kader AA (2000) Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem 48(10):4581–4589

    CAS  CrossRef  PubMed  Google Scholar 

  5. Bala I, Bhardwaj V, Hariharan S, Kumar MN (2006) Analytical methods for assay of ellagic acid and its solubility studies. J Pharm Biomed Anal 40(1):206–210

    CAS  CrossRef  PubMed  Google Scholar 

  6. Marín M, Giner RM, Ríos JL, Recio MC (2013) Intestinal anti-inflammatory activity of ellagic acid in the acute and chronic dextrane sulfate sodium models of mice colitis. J Ethnopharmacol 150(3):925–934

    CrossRef  PubMed  Google Scholar 

  7. Rosillo MA, Sánchez-Hidalgo M, Cárdeno A, Aparicio-Soto M, Sánchez-Fidalgo S, Villegas I, de la Lastra CA (2012) Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in rats. Pharmacol Res 66(3):235–242

    CAS  CrossRef  PubMed  Google Scholar 

  8. Umesalma S, Sudhandiran G (2011) Ellagic acid prevents rat colon carcinogenesis induced by 1, 2 dimethyl hydrazine through inhibition of AKT-phosphoinositide-3 kinase pathway. Eur J Pharmacol 660(2–3):249–258

    CAS  CrossRef  PubMed  Google Scholar 

  9. Xu YM, Deng JZ, Ma J, Chen SN, Marshall R, Jones SH, Johnson RK, Hecht SM (2003) DNA damaging activity of ellagic acid derivatives. Bioorg Med Chem 11:1593–1596

    CAS  CrossRef  PubMed  Google Scholar 

  10. Devipriya N, Sudheer AR, Menon VP (2007) Dose-response effect of ellagic acid oncirculatory antioxidants and lipids during alcohol-induced toxicity in experimental rats. Fundam Clin Pharmacol 21:621–630

    CAS  CrossRef  PubMed  Google Scholar 

  11. Singh K, Khanna AK, Chander R (1999) Hepatoprotective activity of ellagic acid carbon tetrachloride induced hepatotoxicity in rats. Indian J Exp Biol 37:1025–1026

    CAS  PubMed  Google Scholar 

  12. Yu YM, Chang WC, Wu CS, Chiang SY (2005) Reduction of oxidative stress and apoptosis in hyperlipidemic rabbits by ellagic acid. J Nutr Biochem 16:675–681

    CAS  CrossRef  PubMed  Google Scholar 

  13. Pathak RK, Baunthiyal M, Taj G, Kumar A (2014) Virtual screening of natural inhibitors to the predicted HBx protein structure of Hepatitis B Virus using molecular docking for identification of potential lead molecules for liver cancer. Bioinformation 10:428–435

    CrossRef  PubMed  PubMed Central  Google Scholar 

  14. Reddy BU, Mullick R, Kumar A, Sudha G, Srinivasan N, Das S (2014) Small molecule inhibitors of HCV replication from Pomegranate. Sci Rep 4:1–10

    CAS  CrossRef  Google Scholar 

  15. Ajala OS, Jukov A, Ma CM (2014) Hepatitis C virus inhibitory hydrolysable tanninsfrom the fruits of Terminalia chebula. Fitoterapia 99:117–123

    CAS  CrossRef  PubMed  Google Scholar 

  16. Ulrich P, Cerami A (2001) Protein glycation, diabetes, and aging. Recent Prog Horm Res 56:1–21

    CAS  CrossRef  PubMed  Google Scholar 

  17. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer’s disease. Nature 382(6593):685–691

    CAS  CrossRef  PubMed  Google Scholar 

  18. Srikanth V, Maczurek A, Phan T, Steele M, Westcott B, Juskiw D, Münch G (2011) Advanced glycation endproducts and their receptor RAGE in Alzheimer’s disease. Neurobiol Aging 32(5):763–777

    CAS  CrossRef  PubMed  Google Scholar 

  19. Liu W, Ma H, Frost L, Yuan T, Dain JA, Seeram NP (2014) Pomegranate phenolics inhibit formation of advanced glycation endproducts by scavenging reactive carbonyl species. Food Funct 5(11):2996–3004

    CAS  CrossRef  PubMed  Google Scholar 

  20. Rojanathammanee L, Puig KL, Combs CK (2013) Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a transgenic mouse model of Alzheimer disease. J Nutr 143(5):597–605

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  21. Fatima N, Hafizur RM, Hameed A, Ahmed S, Nisar M, Kabir N (2015) Ellagic acid in Emblica officinalis exerts anti-diabetic activity through the action on β-cells of pancreas. Eur J Nutr. doi:10.1007/s00394-015-1103-y

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Giuseppe Derosa or Amirhossein Sahebkar .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Derosa, G., Maffioli, P., Sahebkar, A. (2016). Ellagic Acid and Its Role in Chronic Diseases. In: Gupta, S., Prasad, S., Aggarwal, B. (eds) Anti-inflammatory Nutraceuticals and Chronic Diseases. Advances in Experimental Medicine and Biology, vol 928. Springer, Cham. https://doi.org/10.1007/978-3-319-41334-1_20

Download citation